
long-term prognosis response schizophrenic children 
drug therapy: controlled study trifluoperazine. 
   evident study treatment 
control groups must matched severity illness, 
since affects responsiveness pharmacological 
well types treatments.  use 
double-blind technique guarantee 
well-controlled study; comparison 2 
treatment regimes may misleading groups 
matched, matching based critical 
factors.  study, response nonpharmacologic 
aspects treatment type 
response drug related initial 
severity language impairment.  thus major developmental 
defect determines long-term outcome 
schizophrenic children group also predicted 
immediate responsiveness treatment.  within 
2 major prognostic subgroups young schizophrenic 
children, speech without, children 
different profiles disordered development 
different patterns assets handicaps. 
